NEXOGEST-250 Injection contains Hydroxyprogesterone Caproate 250 mg, a long-acting progestin used to support pregnancy and manage various gynecological conditions associated with progesterone deficiency. It helps maintain the uterine lining, supports normal pregnancy, and reduces uterine contractions when prescribed for appropriate clinical indications. NEXOGEST-250 Injection is commonly used in the management of threatened miscarriage, recurrent pregnancy loss due to progesterone deficiency, prevention of preterm birth in selected patients, and certain menstrual disorders under medical supervision. It is administered by intramuscular injection and should be used only as directed by a qualified healthcare professional. For safe and effective treatment, NEXOGEST-250 Injection should be administered strictly as advised by your doctor or healthcare professional.
